Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
about
The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.Into the Moment: Does Mindfulness Affect Biological Pathways in Multiple Sclerosis?Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis studyQuantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients
P2860
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Monitoring disease activity in ...... m neurofilament light protein.
@en
Monitoring disease activity in ...... m neurofilament light protein.
@nl
type
label
Monitoring disease activity in ...... m neurofilament light protein.
@en
Monitoring disease activity in ...... m neurofilament light protein.
@nl
prefLabel
Monitoring disease activity in ...... m neurofilament light protein.
@en
Monitoring disease activity in ...... m neurofilament light protein.
@nl
P2093
P2860
P50
P1433
P1476
Monitoring disease activity in ...... m neurofilament light protein.
@en
P2093
Fredrik Piehl
Markus Axelsson
Martin Gunnarsson
Peter Sundström
Tomas Olsson
P2860
P304
P356
10.1212/WNL.0000000000004683
P407
P577
2017-10-27T00:00:00Z